Form 4: Tarsus Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
William J Link, a Director of Tarsus Pharmaceuticals, Inc., sold 12,500 shares of common stock on September 15, 2026.
Summary
- Option exercise/conversion: acquired 201 Common Stock on September 15, 2026; holds 106,987 after (Direct).
- Open-market sale: disposed of 11,675 Common Stock at $78.33 ($914,503) on September 15, 2026; holds 95,312 after (Direct).
- Open-market sale: disposed of 759 Common Stock at $79.00 ($59,961) on September 15, 2026; holds 94,553 after (Direct).
- Open-market sale: disposed of 66 Common Stock at $80.01 ($5,281) on September 15, 2026; holds 94,487 after (Direct).
- Option exercise/conversion: disposed of 201 Restricted Stock Units on September 15, 2026; holds 605 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $979,744 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
William J Link — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Common Stock | 201 | — | — | 106,987 |
| 2026-09-15 | Open-market sale | Common Stock | 11,675 | $78 | $914.5K | 95,312 |
| 2026-09-15 | Open-market sale | Common Stock | 759 | $79 | $60.0K | 94,553 |
| 2026-09-15 | Open-market sale | Common Stock | 66 | $80 | $5.3K | 94,487 |
| 2026-09-15 | Option exercise/conversion | Restricted Stock Units | 201 | — | — | 605 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (201 shares) |
| 2026-09-15 | Open-market sale (11,675 shares) |
| 2026-09-15 | Open-market sale (759 shares) |
| 2026-09-15 | Open-market sale (66 shares) |
| 2026-09-15 | Option exercise/conversion (201 shares) |
Keywords
insider transaction, Form 4, TARS, Tarsus Pharmaceuticals, Inc., bearish, William J Link
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.